Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03118583 · ClinicalTrials.gov registry record · NA
Effects of a Dietary Supplement on Lipoprotein Lipids and Inflammatory Markers
A NA study, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03118583 is a NA study that has completed, run by Midwest Center for Metabolic and Cardiovascular Research. The registered enrollment target is 12 participants.
The verdict
NCT03118583, a NA study, has completed, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The goal of this study is to assess the effects of a dietary supplement on fasting lipoprotein lipids and a marker of inflammation in men and women with levels of low-density lipoprotein cholesterol above desirable levels.
Interventions
- DIETARY_SUPPLEMENT 300 mg/day of dietary supplement containing carrageenan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-03-15 |
| Est. Completion | 2018-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03118583
The ClinicalTrials.gov registry entry for NCT03118583 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Midwest Center for Metabolic and Cardiovascular Research, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 300 mg/day of dietary supplement containing carrageenan is the first listed.
NCT03118583 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03118583 about?
NCT03118583 is a clinical study titled "Effects of a Dietary Supplement on Lipoprotein Lipids and Inflammatory Markers". The goal of this study is to assess the effects of a dietary supplement on fasting lipoprotein lipids and a marker of inflammation in men and women with levels of low-density lipoprotein cholesterol above desirable levels.
What is the current status of trial NCT03118583?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2017-03-15. Estimated completion is 2018-01-31.
What interventions are being tested in trial NCT03118583?
The interventions under investigation include: 300 mg/day of dietary supplement containing carrageenan (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03118583?
This trial is sponsored by Midwest Center for Metabolic and Cardiovascular Research, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.